Current approaches and future role of high content imaging in safety sciences and drug discovery
Current approaches and future role of high content imaging in safety sciences and drug discovery
Date
2014
Authors
van Vliet, Erwin
Beilmann, Mario
Davies, Anthony
Fava, Eugenio
Fleck, Roland
Jule, Yvon
Kansy, Manfred
Kustermann, Stefan
Macko, Peter
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published in
Alternatives to Animal Experimentation : ALTEX ; 31 (2014), 4. - pp. 479-493. - ISSN 1868-596X. - eISSN 1868-8551
Abstract
High content imaging combines automated microscopy with image analysis approaches to simultaneously quantify multiple phenotypic and/or functional parameters in biological systems. The technology has become an important tool in the fields of safety sciences and drug discovery, because it can be used for mode-of-action identification, determination of hazard potency and the discovery of toxicity targets and biomarkers. In contrast to conventional biochemical endpoints, high content imaging provides insight into the spatial distribution and dynamics of responses in biological systems. This allows the identification of signaling pathways underlying cell defense, adaptation, toxicity and death. Therefore, high content imaging is considered a promising technology to address the challenges for the Toxicity testing in the 21st century approach. Currently, high content imaging technologies are frequently applied in academia for mechanistic toxicity studies and in pharmaceutical industry for the ranking and selection of lead drug compounds or to identify/confirm mechanisms underlying effects observed in vivo. A recent workshop gathered scientists working on high content imaging in academia, pharmaceutical industry and regulatory bodies with the objective to compile the state-of-the-art of the technology in the different institutions. Together they defined technical and methodological gaps, proposed quality control measures and performance standards, highlighted cell sources and new readouts and discussed future requirements for regulatory implementation. This review summarizes the discussion, proposed solutions and recommendations of the specialists contributing to the workshop.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
high content imaging, toxicology, drug development, toxicity pathways, mechanistic safety screening
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
VAN VLIET, Erwin, Mardas DANESHIAN, Mario BEILMANN, Anthony DAVIES, Eugenio FAVA, Roland FLECK, Yvon JULE, Manfred KANSY, Stefan KUSTERMANN, Peter MACKO, William MUNDY, Adrian ROTH, Christoph SACHSE, Imran SHAH, Marianne UTENG, Bob VAN DE WATER, Thomas HARTUNG, Marcel LEIST, 2014. Current approaches and future role of high content imaging in safety sciences and drug discovery. In: Alternatives to Animal Experimentation : ALTEX. 31(4), pp. 479-493. ISSN 1868-596X. eISSN 1868-8551. Available under: doi: 10.14573/altex.1405271BibTex
@article{vanVliet2014Curre-30054, year={2014}, doi={10.14573/altex.1405271}, title={Current approaches and future role of high content imaging in safety sciences and drug discovery}, number={4}, volume={31}, issn={1868-596X}, journal={Alternatives to Animal Experimentation : ALTEX}, pages={479--493}, author={van Vliet, Erwin and Daneshian, Mardas and Beilmann, Mario and Davies, Anthony and Fava, Eugenio and Fleck, Roland and Jule, Yvon and Kansy, Manfred and Kustermann, Stefan and Macko, Peter and Mundy, William and Roth, Adrian and Sachse, Christoph and Shah, Imran and Uteng, Marianne and van de Water, Bob and Hartung, Thomas and Leist, Marcel} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/30054"> <dc:creator>Beilmann, Mario</dc:creator> <dc:creator>Kansy, Manfred</dc:creator> <dc:contributor>Davies, Anthony</dc:contributor> <dc:creator>Shah, Imran</dc:creator> <dc:creator>Daneshian, Mardas</dc:creator> <dc:contributor>Roth, Adrian</dc:contributor> <dc:contributor>Mundy, William</dc:contributor> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/30054/3/Vliet_0-264743.pdf"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-02-25T11:10:59Z</dc:date> <dc:contributor>Kustermann, Stefan</dc:contributor> <dc:creator>Jule, Yvon</dc:creator> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>van de Water, Bob</dc:creator> <dc:contributor>Daneshian, Mardas</dc:contributor> <dc:contributor>Jule, Yvon</dc:contributor> <dc:contributor>Fleck, Roland</dc:contributor> <dc:creator>Macko, Peter</dc:creator> <dc:contributor>Hartung, Thomas</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Shah, Imran</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <dc:contributor>Kansy, Manfred</dc:contributor> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/30054"/> <dc:language>eng</dc:language> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:rights>Attribution 4.0 International</dc:rights> <dc:creator>Roth, Adrian</dc:creator> <dcterms:title>Current approaches and future role of high content imaging in safety sciences and drug discovery</dcterms:title> <dc:creator>Kustermann, Stefan</dc:creator> <dc:contributor>Sachse, Christoph</dc:contributor> <dc:creator>Fleck, Roland</dc:creator> <dc:creator>Hartung, Thomas</dc:creator> <dc:creator>Mundy, William</dc:creator> <dc:contributor>Beilmann, Mario</dc:contributor> <dc:contributor>van Vliet, Erwin</dc:contributor> <dc:creator>Sachse, Christoph</dc:creator> <dc:contributor>Macko, Peter</dc:contributor> <dc:creator>van Vliet, Erwin</dc:creator> <dc:creator>Fava, Eugenio</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:issued>2014</dcterms:issued> <dc:contributor>Fava, Eugenio</dc:contributor> <dc:creator>Uteng, Marianne</dc:creator> <dc:contributor>van de Water, Bob</dc:contributor> <dc:contributor>Uteng, Marianne</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-02-25T11:10:59Z</dcterms:available> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:creator>Davies, Anthony</dc:creator> <dcterms:abstract xml:lang="eng">High content imaging combines automated microscopy with image analysis approaches to simultaneously quantify multiple phenotypic and/or functional parameters in biological systems. The technology has become an important tool in the fields of safety sciences and drug discovery, because it can be used for mode-of-action identification, determination of hazard potency and the discovery of toxicity targets and biomarkers. In contrast to conventional biochemical endpoints, high content imaging provides insight into the spatial distribution and dynamics of responses in biological systems. This allows the identification of signaling pathways underlying cell defense, adaptation, toxicity and death. Therefore, high content imaging is considered a promising technology to address the challenges for the Toxicity testing in the 21st century approach. Currently, high content imaging technologies are frequently applied in academia for mechanistic toxicity studies and in pharmaceutical industry for the ranking and selection of lead drug compounds or to identify/confirm mechanisms underlying effects observed in vivo. A recent workshop gathered scientists working on high content imaging in academia, pharmaceutical industry and regulatory bodies with the objective to compile the state-of-the-art of the technology in the different institutions. Together they defined technical and methodological gaps, proposed quality control measures and performance standards, highlighted cell sources and new readouts and discussed future requirements for regulatory implementation. This review summarizes the discussion, proposed solutions and recommendations of the specialists contributing to the workshop.</dcterms:abstract> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/30054/3/Vliet_0-264743.pdf"/> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes